BMSBI416.BULLETININTELLIGENCE.COM HOST
We discovered that the main root page on bmsbi416.bulletinintelligence.com took seven hundred and nineteen milliseconds to load. I could not detect a SSL certificate, so in conclusion our crawlers consider bmsbi416.bulletinintelligence.com not secure.
Internet Address
65.220.57.123
FAVORITE ICON
SERVER OPERATING SYSTEM
I observed that this website is implementing the Microsoft-IIS/7.5 os.TITLE
Bulletin Intelligence on Bristol-Myers Squibb Company - BriefingDESCRIPTION
Bulletin Intelligence on Bristol-Myers Squibb Company. Bulletin Intelligence on Bristol-Myers Squibb Company. Continuous, independent analysis of news and open-source data by Bulletin Intelligence LLC. Acorda Acquires Finnish Biotie For PhIII Parkinsons Drug In 363 Million Deal. Bristol-Myers Squibb in the News. Frakt Debating Drug Price Reductions Can Moderate Prices. Study Suggests PD-1 Inhibitors Could Be Used To Treat Alzheimers. Recent Pharma News Media Coverage Largely Directed At Pfizer, Merck.CONTENT
This domain bmsbi416.bulletinintelligence.com had the following in the web site, "Bulletin Intelligence on Bristol-Myers Squibb Company." Our analyzers observed that the website stated " Bulletin Intelligence on Bristol-Myers Squibb Company." The Website also stated " Continuous, independent analysis of news and open-source data by Bulletin Intelligence LLC. Acorda Acquires Finnish Biotie For PhIII Parkinsons Drug In 363 Million Deal. Bristol-Myers Squibb in the News. Frakt Debating Drug Price Reductions Can Moderate Prices. Study Suggests PD-1 Inhibitors Could Be Used To Treat Alzheimers. Recent Pharma News Media Coverage Largely Directed At Pfizer, Merck."